MedTrace Logo

A Study of the Natural Course of SURF1 Deficiency

NCT05277363 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-05-20

No results posted yet for this study

Summary

The purpose of the study is to prospectively and systematically collect standardized clinical information, to describe important features of the disease course of SURF1 deficiency. These include but are not limited to symptomatology, clinical course, and risk factors for severe disease and complications.

Conditions

  • Leigh Syndrome

Interventions

OTHER

None (Observational study)

No investigational intervention, marketed product, or placebo will be administered to study participants in this study.

Sponsors & Collaborators

  • Taysha Gene Therapies, Inc.

    lead INDUSTRY

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-04
Primary Completion
2022-05-04
Completion
2022-05-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05277363 on ClinicalTrials.gov